光伏板塊拉昇走強 明年新增裝機目標1.2億千瓦
格隆匯12月23日丨光伏板塊拉昇走強,億晶光電漲停,陽光電源漲超7%,中來股份、晶澳科技、拓日新能、隆基股份等紛紛走高。

中國能源政策研究年會2020暨“中國電力圓桌”四季度會議22日在京召開。有代表在會上表示,國家能源局已經提出了“2021年我國風電、太陽能發電合計新增1.2億千瓦”的目標。該消息也得到了國家能源局相關人士的證實。這標誌着我國新能源行業年度新增裝機規劃將首次突破1億千瓦。
國家能源局黨組書記、局長章建華在會議上指出,要加快風電光伏發展,風電、光伏發電新增裝機總量較“十三五”有大幅增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.